Man Group Portfolio holdings
AUM
$46.3B
1-Year Return
20.09%
This Quarter Return
+2.5%
1 Year Return
+20.09%
3 Year Return
+87.95%
5 Year Return
+152.77%
10 Year Return
–
AUM
$37.9B
AUM Growth
+$742M
(+2%)
Cap. Flow
-$861M
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
2,202
New
218
Increased
760
Reduced
759
Closed
330
Top Buys
| 1 |
CRH
CRH
|
+$187M |
| 2 |
SBA Communications
SBAC
|
+$141M |
| 3 |
lululemon athletica
LULU
|
+$125M |
| 4 |
Northrop Grumman
NOC
|
+$122M |
| 5 |
Vistra
VST
|
+$122M |
Top Sells
| 1 |
TSMC
TSM
|
+$394M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$155M |
| 3 |
Booking.com
BKNG
|
+$134M |
| 4 |
Dynatrace
DT
|
+$131M |
| 5 |
HP
HPQ
|
+$128M |
Sector Composition
| 1 | Technology | 24.64% |
| 2 | Consumer Discretionary | 12.63% |
| 3 | Healthcare | 12.27% |
| 4 | Financials | 11.14% |
| 5 | Industrials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
EverQuote
EVER
$849M
| $236K | ﹤0.01% |
+11,294
| New | +$236K |
|
|
PSTX
1602
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $235K | ﹤0.01% |
80,576
+939
| +1% | +$2.74K |
|
1603
Nurix Therapeutics
NRIX
$684M
| $234K | ﹤0.01% |
+11,225
| New | +$234K |
|
1604
ThredUp
TDUP
$1.33B
| $234K | ﹤0.01% |
+137,658
| New | +$234K |
|
1605
Diamond Hill
DHIL
$387M
| $232K | ﹤0.01% |
+1,651
| New | +$232K |
|
1606
MindMed
MNMD
$710M
| $231K | ﹤0.01% |
32,062
-80,115
| -71% | -$578K |
|
1607
DLH Holdings
DLHC
$79.4M
| $231K | ﹤0.01% |
21,849
-18,452
| -46% | -$195K |
|
1608
LiveOne
LVO
$58.6M
| $229K | ﹤0.01% |
145,608
+94,770
| +186% | +$149K |
|
1609
StepStone Group
STEP
$4.81B
| $228K | ﹤0.01% |
4,971
-5,154
| -51% | -$237K |
|
1610
Unitil
UTL
$812M
| $227K | ﹤0.01% |
4,389
-9,558
| -69% | -$495K |
|
1611
OP Bancorp
OPBK
$217M
| $221K | ﹤0.01% |
23,078
+208
| +0.9% | +$2K |
|
1612
Amylyx Pharmaceuticals
AMLX
$1.05B
| $221K | ﹤0.01% |
116,129
+55,450
| +91% | +$105K |
|
1613
Herc Holdings
HRI
$4.43B
| $220K | ﹤0.01% |
+1,650
| New | +$220K |
|
1614
First Business Financial Services
FBIZ
$431M
| $219K | ﹤0.01% |
5,929
-6
| -0.1% | -$222 |
|
1615
Bentley Systems
BSY
$16B
| $218K | ﹤0.01% |
+4,425
| New | +$218K |
|
|
TBI
1616
Trueblue
TBI
$171M
| $218K | ﹤0.01% |
+21,200
| New | +$218K |
|
1617
Benchmark Electronics
BHE
$1.43B
| $218K | ﹤0.01% |
+5,528
| New | +$218K |
|
1618
WEX
WEX
$5.81B
| $217K | ﹤0.01% |
+1,226
| New | +$217K |
|
1619
Invivyd
IVVD
$270M
| $216K | ﹤0.01% |
196,598
+54,577
| +38% | +$60K |
|
|
PRSU
1620
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.02B
| $216K | ﹤0.01% |
+6,358
| New | +$216K |
|
1621
INmune Bio
INMB
$46.8M
| $215K | ﹤0.01% |
24,388
-16,161
| -40% | -$143K |
|
1622
XPeng
XPEV
$19.1B
| $213K | ﹤0.01% |
29,100
+8,400
| +41% | +$61.6K |
|
1623
Third Coast Bancshares
TCBX
$546M
| $213K | ﹤0.01% |
+10,021
| New | +$213K |
|
1624
Scansource
SCSC
$948M
| $213K | ﹤0.01% |
+4,797
| New | +$213K |
|
|
DCBO
1625
Docebo
DCBO
$863M
| $212K | ﹤0.01% |
+5,500
| New | +$212K |
|